Dynova Laboratories

Parsippany Troy Hills, United States Founded: 2006 • Age: 20 yrs
Specializes in acquiring and developing natural nutraceutical supplements.

About Dynova Laboratories

Dynova Laboratories was a Healthcare company based in Parsippany Troy Hills (United States) founded in 2006. It specializes in acquiring and developing natural nutraceutical supplements. It operates on a B2B model. Dynova Laboratories has raised $15 million across 1 funding round from investors including Aisling Capital. Dynova Laboratories has completed 1 acquisition, including Sinus Buster. The company is recorded as dissolved. Its focus areas include Health and Pharmaceuticals, Nutraceuticals, Supplements and Natural Products. Its legal entity is Dynova Laboratories Inc. Its competitors include Zivo Bioscience, Zarbees and InterHealth Nutraceuticals; 2 of its 3 listed competitors have raised funding.

Company details

Dynova Laboratories, based in Parsippany Troy Hills, focuses on health and pharmaceuticals, nutraceuticals, focusing on dietary supplements, and natural products. Specializes in acquiring and developing natural nutraceutical supplements. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Parsippany Troy Hills, United States
  • Sectors
    Healthcare
  • Website dynovalabs.com
  • Legal Name Dynova Laboratories Inc
Key Metrics
  • Total Equity Funding
    $15M (USD)

    in 1 rounds

  • Latest Funding Round
    $15M (USD), Series B

    Dec 2009

  • Investors
  • Investments & Acquisitions

Funding Insights of Dynova Laboratories

Dynova Laboratories has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in December 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $15M
  • Total Rounds 1
  • Last Round Series B β€” $15M
  • First Round $15M

    (Dec 2009)

  • Investors Count 1

All 1 funding rounds of Dynova Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2009$15MSeries B–Aisling Capital
–
Valuation history

1 investors in total: 1 institutional.

Investors in Dynova Laboratories

Dynova Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Aisling Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
PE firm investing in the US
aislingcapital.comNew York, United States
Premium access

Investor details for Dynova Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Dynova Laboratories

Dynova Laboratories has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sinus Buster.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Manufacturer of drugs
sinusbuster.comAlbany, United States2003Jan 2008β€’β€’β€’β€’
Premium access

Complete acquisition details for Dynova Laboratories

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Dynova Laboratories

3 dated milestones of Dynova Laboratories across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Dynova Laboratories is founded.
  2. Acquisition Acquires Sinus Buster.
  3. Funding First funding round of $15.0M.

Competitors of Dynova Laboratories

Dynova Laboratories has 3 listed competitors in our database, 2 of them funded. They include Zivo Bioscience, Zarbees and InterHealth Nutraceuticals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
zivobioscience.com1983Keego Harbor, United States$962,00010
Bioactive compounds from algal strain
zarbees.com2008Draper, United States$28.28M
Natural cough remedies and wellness products are developed by Zarbees.
interhealthusa.com1987Benicia, United States33
Nutraceutical and specialty ingredients are researched, developed, and supplied.
Premium access

Detailed competitors of Dynova Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Dynova Laboratories (Alternative Medicine Products) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical therapies for smell and taste loss are developed.
2014Washington, District Of Columbia, United StatesUSD 25.88 M
Homeopathic medicines are supplied and distributed by Boiron worldwide.
1932Newtown Square, Pennsylvania, United States
Manufacturer of herbal medicines
2009Wilmington, Delaware, United StatesUSD 2.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dynova Laboratories

Premium access

Complete news archive for Dynova Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dynova Laboratories

Dynova Laboratories was founded in 2006 and raised its 1st funding round 3 years after it was founded.

Dynova Laboratories is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.

Dynova Laboratories is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series B of $15M, raised on Dec 2009.

Dynova Laboratories, based in Parsippany Troy Hills, focuses on health and pharmaceuticals, nutraceuticals, focusing on dietary supplements, and natural products. Specializes in acquiring and developing natural nutraceutical supplements. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Dynova Laboratories's top competitors include Zivo Bioscience, Zarbees and InterHealth Nutraceuticals.

Dynova Laboratories has made 1 acquisition, including Sinus Buster.

Dynova Laboratories has 1 investor. Key investors include Aisling Capital.

Dynova Laboratories operates through Dynova Laboratories Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available